ACTRN12615000027516已完成未知
Single-centre, open-label, pilot study of Celgro(tm) collagen membrane for guided bone regeneration around exposed dental implants in patients undergoing dental implant surgery
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
入排标准
- 年龄范围
- 18 Years 至 75 Years（—）
- 性别
- All
入选标准
- •Participant requires one or more dental implants with simultaneous bone augmentation procedure
- •- Tooth extraction procedure was performed prior to simultaneous augmentation procedure with no complications
- •- Female participants of child-bearing potential must:
- •*Have a negative pregnancy test within 72 hours of visit 1
- •*Agree not to fall pregnant while on the study
- •- Non-smoker
- •- Able to comply with the requirements of the protocol, including post-operative oral hygiene and attendance for follow-up procedures
- •- Able to give informed consent or has legally acceptable representative who can give informed consent in accordance with ICH/GCP
排除标准
- •- Insulin-dependent, uncontrolled or poorly-controlled diabetes mellitus
- •- History of malignancy, radiotherapy or chemotherapy within the last 5 years
- •- Female participant who is pregnant or lactating
- •- Participant is taking medication that may have an effect on bone turnover or mucosal healing
- •- General contraindications for dental and/or surgical treatment
- •- Concurrent disease or medical condition which affects bone or connective tissue metabolism
- •- Known hypersensitivity to collagen
- •- Known substance abuse
- •- Participation in another study with an investigational product within previous 3 months
- •- Other clinically significant disease (including psychological disorders) or medical condition that would, in the opinion of the investigator, compromise the safety or the participant or the outcome of the study
研究者
相似试验
进行中（未招募）
不适用
Islet transplantation at the onset of diabetes mellitus type 1Type 1 diabetesEUCTR2014-004110-28-ITIRCCS Ospedale San Raffaele6
招募中
不适用
A single-arm, open-label, multi-centre pilot study evaluating the efficacy and safety of Ro 25-8310 combination therapy with Ro 20-9963 in pateints with chronic hepatitis C attending a methdone clinicChronic hepatitis CInflammatory and Immune System - LiverACTRN12605000682640Melbourne Health50
招募中
4 期
A single-arm, open-label, pilot study evaluating the efficacy and safety of directly observed peginterferon alfa-2a with ribavirin in conjunction with a peer counsellor in patients actively using injecting drugs who have chronic hepatitis C and attend a drug and alcohol centre.Impact of standard pharmacotherapy treatment of chronic Hepatitis C virus (HCV) infection on: (i) quality of life, (ii) mental health status, (iii) injecting drug behaviours, and (iv) opioid pharmacotherapy use in active injecting drug users (IDUs).Side effects related to chronic Hepatitis C virus (HCV) infection and treatment in active injecting drug users (IDUs).Factors affecting compliance of active injecting drug users (IDUs) for standard pharmacotherapy treatment of chronic Hepatitis C virus (HCV) infection.Chronic hepatitis C virus (HCV) infection.Public Health - Other public healthMental Health - AddictionInfection - Other infectious diseasesACTRN12608000400369Dr Joe Sasadeusz50
招募中
1 期
Pentosan Polysulfate Sodium (PPS) in subjects with mucopolysaccharidosis type I (MPS I)Mucopolysaccharidosis type I (MPS I)Metabolic and Endocrine - Metabolic disordersHuman Genetics and Inherited Disorders - Other human genetics and inherited disordersACTRN12620000823976Paradigm Biopharmaceuticals Pty Ltd10
进行中（未招募）
1 期
A pilot, open-label, multi-center clinical trial to investigate the safety and efficacy of Bovine-Calf Intestinal Alkaline Phosphatase in patients with moderate to severe ulcerative colitisInflammatory Bowel DiseaseEUCTR2006-000197-69-CZAM-Pharma B.V.24